<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcbiochem&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Biochemistry - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcbiochem/</link>
        <description>The latest research articles published by BMC Biochemistry</description>
        <dc:date>2009-10-28T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/26" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/25" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/24" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/23" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/22" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/21" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/20" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/19" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/18" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/10/17" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/26">
        <title>Biosynthesis of the proteasome inhibitor syringolin A: the ureido group joining two amino acids originates from bicarbonate</title>
        <description>Background:
Syringolin A, an important virulence factor in the interaction of the phytopathogenic bacterium Pseudomonas syringae pv. syringae B728a with its host plant Phaseolus vulgaris (bean), was recently shown to irreversibly inhibit eukaryotic proteasomes by a novel mechanism. Syringolin A is synthesized by a mixed non-ribosomal peptide synthetase/polyketide synthetase and consists of a tripeptide part including a twelve-membered ring with an N-terminal valine that is joined to a second valine via a very unusual ureido group. Analysis of sequence and architecture of the syringolin A synthetase gene cluster with the five open reading frames sylA-sylE allowed to formulate a biosynthesis model that explained all structural features of the tripeptide part of syringolin A but left the biosynthesis of the unusual ureido group unaccounted for.
Results:
We have cloned a 22 kb genomic fragment containing the sylA-sylE gene cluster but no other complete gene into the broad host range cosmid pLAFR3. Transfer of the recombinant cosmid into Pseudomonas putida and P. syringae pv. syringae SM was sufficient to direct the biosynthesis of bona fide syringolin A in these heterologous organisms whose genomes do not contain homologous genes. NMR analysis of syringolin A isolated from cultures grown in the presence of NaH13CO3 revealed preferential 13C-labeling at the ureido carbonyl position.
Conclusion:
The results show that no additional syringolin A-specific genes were needed for the biosynthesis of the enigmatic ureido group joining two amino acids. They reveal the source of the ureido carbonyl group to be bicarbonate/carbon dioxide, which we hypothesize is incorporated by carbamylation of valine mediated by the sylC gene product(s). A similar mechanism may also play a role in the biosynthesis of other ureido-group-containing NRPS products known largely from cyanobacteria.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/26</link>
                <dc:creator>Christina Ramel</dc:creator>
                <dc:creator>Micha Tobler</dc:creator>
                <dc:creator>Martin Meyer</dc:creator>
                <dc:creator>Laurent Bigler</dc:creator>
                <dc:creator>Marc-Olivier Ebert</dc:creator>
                <dc:creator>Barbara Schellenberg</dc:creator>
                <dc:creator>Robert Dudler</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:26</dc:source>
        <dc:date>2009-10-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-26</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2009-10-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/25">
        <title>Ser170 of Bacillus thuringiensis Cry1Ab delta-endotoxin becomes anchored in a hydrophobic moiety upon insertion of this protein into Manduca sexta brush border membranes</title>
        <description>Background:
Three spin-labeled mutant proteins, mutated at the beginning, middle, and end of &#945;-helix 5 of the Bacillus thuringiensis Cry1Ab &#948;-endotoxin, were used to study the involvement of these specific amino acid residues in ion transport and to determine conformational changes in the vicinity of these residues when the protein was translocated into a biological membrane.
Results:
Amino acid residue leucine 157, located in the N-terminal portion of &#945;-helix 5, showed no involvement in ion transport, and the environment that surrounds the residue did not show any change when transferred into the biological membrane. Serine 170, located in the middle of the &#945;-helix, showed no involvement in ion transport, but our findings indicate that in the membrane-bound state this residue faces an environment that makes the spin less mobile, as opposed to the mobility observed in an aqueous environment. Serine 176, located in the C-terminal end of the &#945;-helix 5 is shown to be involved in ion transport activity.
Conclusion:
Ion transport data for L157, S170, and S176, along with the mobility of the spin-labels, structural characterization of the resulting proteins, and toxicity assays against a target insect, suggest that the toxin undergoes conformational changes upon protein translocation into the midgut membrane. These conformational changes result in the midregion of the &#945;-helix 5 being exposed to a hydrophobic-like environment. The location of these three residues in the toxin suggests that the entire &#945;-helix becomes inserted in the insect midgut membrane.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/25</link>
                <dc:creator>Oscar Alzate</dc:creator>
                <dc:creator>Craig Hemann</dc:creator>
                <dc:creator>Cristina Osorio</dc:creator>
                <dc:creator>Russ Hille</dc:creator>
                <dc:creator>Donald Dean</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:25</dc:source>
        <dc:date>2009-10-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-25</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2009-10-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/24">
        <title>Mapping of protein phosphatase-6 association with its SAPS domain regulatory subunit using a model of helical repeats</title>
        <description>Background:
Helical repeat motifs are common among regulatory subunits for type-1 and type-2A protein Ser/Thr phosphatases. Yeast Sit4 is a distinctive type-2A phosphatase that has dedicated regulatory subunits named Sit4-Associated Proteins (SAPS). These subunits are conserved, and three human SAPS-related proteins are known to associate with PP6 phosphatase, the Sit4 human homologue.
Results:
Here we show that endogenous SAPS subunit PP6R3 co-precipitates half of PP6 in cell extracts, and the SAPS region of PP6R3 is sufficient for binding PP6. The SAPS domain of recombinant GST-PP6R3 is relatively resistant to trypsin despite having many K and R residues, and the purified SAPS domain (residues 1-513) has a circular dichroic spectrum indicative of mostly alpha helical structure. We used sequence alignments and 3D-jury methods to develop alternative models for the SAPS domain, based on available structures of other helical repeat proteins. The models were used to select sites for charge-reversal substitutions in the SAPS domain of PP6R3 that were tested by co-precipitation of endogenous PP6c with FLAG-tagged PP6R3 from mammalian cells. Mutations that reduced binding with PP6 suggest that SAPS adopts a helical repeat similar to the structure of p115 golgin, but distinct from the PP2A-A subunit. These mutations did not cause perturbations in overall PP6R3 conformation, evidenced by no change in kinetics or preferential cleavage by chymotrypsin.
Conclusion:
The conserved SAPS domain in PP6R3 forms helical repeats similar to those in golgin p115 and negatively charged residues in interhelical loops are used to associate specifically with PP6. The results advance understanding of how distinctive helical repeat subunits uniquely distribute and differentially regulate closely related Ser/Thr phosphatases.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/24</link>
                <dc:creator>Julien Guergnon</dc:creator>
                <dc:creator>Urszula Derewenda</dc:creator>
                <dc:creator>Jessica Edelson</dc:creator>
                <dc:creator>David Brautigan</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:24</dc:source>
        <dc:date>2009-10-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-24</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2009-10-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/23">
        <title>Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions</title>
        <description>Background:
Cysteine cathepsins are known to primarily cleave their substrates at reducing and acidic conditions within endo-lysosomes. Nevertheless, they have also been linked to extracellular proteolysis, that is, in oxidizing and neutral environments. Although the impact of reducing or oxidizing conditions on proteolytic activity is a key to understand physiological protease functions, redox conditions have only rarely been considered in routine enzyme activity assays. Therefore we developed an assay to test for proteolytic processing of a natural substrate by cysteine cathepsins which accounts for redox potentials and pH values corresponding to the conditions in the extracellular space in comparison to those within endo-lysosomes of mammalian cells.
Results:
The proteolytic potencies of cysteine cathepsins B, K, L and S towards thyroglobulin were analyzed under conditions simulating oxidizing versus reducing environments with neutral to acidic pH values. Thyroglobulin, the precursor molecule of thyroid hormones, was chosen as substrate, because it represents a natural target of cysteine cathepsins. Thyroglobulin processing involves thyroid hormone liberation which, under physiological circumstances, starts in the extracellular follicle lumen before being continued within endo-lysosomes. Our study shows that all cathepsins tested were capable of processing thyroglobulin at neutral and oxidizing conditions, although these are reportedly non-favorable for cysteine proteases. All analyzed cathepsins generated distinct fragments of thyroglobulin at extracellular versus endo-lysosomal conditions as demonstrated by SDS-PAGE followed by immunoblotting or N-terminal sequencing. Moreover, the thyroid hormone thyroxine was liberated by the action of cathepsin S at extracellular conditions, while cathepsins B, K and L worked most efficiently in this respect at endo-lysosomal conditions.
Conclusion:
The results revealed distinct cleavage patterns at all conditions analyzed, indicating compartment-specific processing of thyroglobulin by cysteine cathepsins. In particular, proteolytic activity of cathepsin S towards the substrate thyroglobulin can now be understood as instrumental for extracellular thyroid hormone liberation. Our study emphasizes that the proteolytic functions of cysteine cathepsins in the thyroid are not restricted to endo-lysosomes but include pivotal roles in extracellular substrate utilization. We conclude that understanding of the interplay and fine adjustment of protease networks in vivo is better approachable by simulating physiological conditions in protease activity assays.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/23</link>
                <dc:creator>Silvia Jordans</dc:creator>
                <dc:creator>Sasa Jenko-Kokalj</dc:creator>
                <dc:creator>Nicole Kuhl</dc:creator>
                <dc:creator>Sofia Tedelind</dc:creator>
                <dc:creator>Wolfgang Sendt</dc:creator>
                <dc:creator>Dieter Broemme</dc:creator>
                <dc:creator>Dusan Turk</dc:creator>
                <dc:creator>Klaudia Brix</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:23</dc:source>
        <dc:date>2009-09-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-23</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2009-09-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/22">
        <title>Identification of a nuclear localization motif in the serine/arginine protein kinase PSRPK of physarum polycephalum</title>
        <description>Background:
Serine/arginine (SR) protein-specific kinases (SRPKs) are conserved in a wide range of organisms, from humans to yeast. Studies showed that SRPKs can regulate the nuclear import of SR proteins in cytoplasm, and regulate the sub-localization of SR proteins in the nucleus. But no nuclear localization signal (NLS) of SRPKs was found. We isolated an SRPK-like protein PSRPK (GenBank accession No. DQ140379) from Physarum polycephalum previously, and identified a NLS of PSRPK in this study.
Results:
We carried out a thorough molecular dissection of the different domains of the PSRPK protein involved in its nuclear localization. By truncation of PSRPK protein, deletion of and single amino acid substitution in a putative NLS and transfection of mammalian cells, we observed the distribution of PSRPK fluorescent fusion protein in mammalian cells using confocal microscopy and found that the protein was mainly accumulated in the nucleus; this indicated that the motif contained a nuclear localization signal (NLS). Further investigation with truncated PSPRK peptides showed that the NLS (318PKKGDKYDKTD328) was localized in the alkaline &#937;-loop of a helix-loop-helix motif (HLHM) of the C-terminal conserved domain. If the 318PKKGDK322 sequence was deleted from the loop or K320 was mutated to T320, the PSRPK fluorescent fusion protein could not enter and accumulate in the nucleus.
Conclusion:
This study demonstrated that the 318PKKGDKYDKTD328 peptides localized in the C-terminal conserved domain of PSRPK with the &#937;-loop structure could play a crucial role in the NLS function of PSRPK.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/22</link>
                <dc:creator>Shi-De Liu</dc:creator>
                <dc:creator>Zhuo-Long Zhou</dc:creator>
                <dc:creator>Zi-Yang Lin</dc:creator>
                <dc:creator>Qiu-Ling Ouyang</dc:creator>
                <dc:creator>Jian-Hua Zhang</dc:creator>
                <dc:creator>Sheng-Li Tian</dc:creator>
                <dc:creator>Miao Xing</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:22</dc:source>
        <dc:date>2009-08-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-22</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2009-08-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/21">
        <title>Contribution of oenocytes and pheromones to courtship behaviour in Drosophila</title>
        <description>Background:
In Drosophila, cuticular sex pheromones are long-chain unsaturated hydrocarbons synthesized from fatty acid precursors in epidermal cells called oenocytes. The species D. melanogaster shows sex pheromone dimorphism, with high levels of monoenes in males, and of dienes in females. Some biosynthesis enzymes are expressed both in fat body and oenocytes, rendering it difficult to estimate the exact role of oenocytes and of the transport of fatty acids from fat body to oenocytes in pheromone elaboration. To address this question, we RNAi silenced two main genes of the biosynthesis pathway, desat1 and desatF, in the oenocytes of D. melanogaster, without modifying their fat body expression.
Results:
Inactivation of desat1 in oenocytes resulted in a 96% and 78% decrease in unsaturated hydrocarbons in males and females, respectively. Female pheromones (dienes) showed a decrease of 90%. Inactivation of desatF, which is female-specific and responsible for diene formation, resulted in a dramatic loss of pheromones (-98%) paralleled with a two-fold increase in monoenes. Courtship parameters (especially courtship latency) from wild-type males were more affected by desat1 knocked-down females (courtship latency increased by four fold) than by desatF knocked-down ones (+65% of courtship latency).The number of transcripts in oenocytes was estimated at 0.32 and 0.49 attomole/&#956;g for desat1 in males and females, respectively, about half of the total transcripts in a fly. There were only 0.06 attomole/&#956;g desatF transcripts in females, all located in the oenocytes.
Conclusion:
Knock-down results for desat1 suggest that there must be very little transport of unsaturated precursors from fat body to the oenocytes, so pheromone synthesis occurs almost entirely through the action of biosynthesis enzymes within the oenocytes. Courtship experiments allow us to discuss the behavioral role of diene pheromones, which, under special conditions, could be replaced by monoenes in D. melanogaster. A possible explanation is given of how pheromones could have evolved in species such as D. simulans, which only synthesize monoenes.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/21</link>
                <dc:creator>Claude Wicker-Thomas</dc:creator>
                <dc:creator>Ilhem Guenachi</dc:creator>
                <dc:creator>Youssouf Keita</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:21</dc:source>
        <dc:date>2009-08-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-21</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2009-08-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/20">
        <title>Biochemical characterization of malate synthase G of P. aeruginosa</title>
        <description>Background:
Malate synthase catalyzes the second step of the glyoxylate bypass, the condensation of acetyl coenzyme A and glyoxylate to form malate and coenzyme A (CoA). In several microorganisms, the glyoxylate bypass is of general importance to microbial pathogenesis. The predicted malate synthase G of Pseudomonas aeruginosa has also been implicated in virulence of this opportunistic pathogen.
Results:
Here, we report the verification of the malate synthase activity of this predicted protein and its recombinant production in E. coli, purification and biochemical characterization. The malate synthase G of P. aeruginosa PAO1 has a temperature and pH optimum of 37.5&#176;C and 8.5, respectively. Although displaying normal thermal stability, the enzyme was stable up to incubation at pH 11. The following kinetic parameters of P. aeruginosa PAO1 malate synthase G were obtained: Km glyoxylate (70 &#956;M), Km acetyl CoA (12 &#956;M) and Vmax (16.5 &#956;mol/minutes/mg enzyme). In addition, deletion of the corresponding gene showed that it is a prerequisite for growth on acetate as sole carbon source.
Conclusion:
The implication of the glyoxylate bypass in the pathology of various microorganisms makes malate synthase G an attractive new target for antibacterial therapy. The purification procedure and biochemical characterization assist in the development of antibacterial components directed against this target in P. aeruginosa.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/20</link>
                <dc:creator>Bart Roucourt</dc:creator>
                <dc:creator>Nikki Minnebo</dc:creator>
                <dc:creator>Patrick Augustijns</dc:creator>
                <dc:creator>Kirsten Hertveldt</dc:creator>
                <dc:creator>Guido Volckaert</dc:creator>
                <dc:creator>Rob Lavigne</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:20</dc:source>
        <dc:date>2009-06-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-20</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>20</prism:startingPage>
        <prism:publicationDate>2009-06-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/19">
        <title>Insights into the role of Val45 and Gln182 of Escherichia coli MutY in DNA substrate binding and specificity </title>
        <description>Background:
Escherichia coli MutY (EcMutY) reduces mutagenesis by removing adenines paired with guanines or 7,8-dihydro-8-oxo-guanines (8-oxoG). V45 and Q182 of EcMutY are considered to be the key determinants of adenine specificity. Both residues are spatially close to each other in the active site and are conserved in MutY family proteins but not in Methanobacterium thermoautotrophicum Mig.MthI T/G mismatch DNA glycosylase (A50 and L187 at the corresponding respective positions).
Results:
Targeted mutagenesis study was performed to determine the substrate specificities of V45A, Q182L, and V45A/Q182L double mutant of EcMutY. All three mutants had significantly lower binding and glycosylase activities for A/G and A/8-oxoG mismatches than the wild-type enzyme. The double mutant exhibited an additive reduction in binding to both the A/G and A/GO in comparison to the single mutants. These mutants were also tested for binding and glycosylase activities with T/G- or T/8-oxoG-containing DNA. Both V45A and Q182L mutants had substantially increased affinities towards T/G, however, they did not exhibit any T/G or T/8-oxoG glycosylase activity. Surprisingly, the V45A/Q182L double mutant had similar binding affinities to T/G as the wild-type EcMutY. V45A, Q182L, and V45A/Q182L EcMutY mutants could not reduce the G:C to T:A mutation frequency of a mutY mutant. Expression of the V45A mutant protein caused a dominant negative phenotype with an increased G:C to A:T mutation frequency.
Conclusion:
The substrate specificities are altered in V45A, Q182L, and V45A/Q182L EcMutY mutants. V45A and Q182L mutants had reduced binding and glycosylase activities for A/G and A/8-oxoG mismatches and increased affinities towards T/G mismatch. However, in contrast to a previous report that Mig.MthI thymine DNA glycosylase can be converted to a MutY-like adenine glycosylase by replacing two residues (A50V and L187Q), both V45A and Q182L EcMutY mutants did not exhibit any T/G or T/8-oxoG glycosylase activity. The dominant negative phenotype of V45A EcMutY mutant protein is probably caused by its increased binding affinity to T/G mismatch and thus inhibiting other repair pathways.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/19</link>
                <dc:creator>Po-Wen Chang</dc:creator>
                <dc:creator>Amrita Madabushi</dc:creator>
                <dc:creator>A-Lien Lu</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:19</dc:source>
        <dc:date>2009-06-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-19</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2009-06-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/18">
        <title>Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol </title>
        <description>Background:
Mycobacterium tuberculosis DNA topoisomerase I is an attractive target for discovery of novel TB drugs that act by enhancing the accumulation of the topoisomerase-DNA cleavage product. It shares a common transesterification domain with other type IA DNA topoisomerases. There is, however, no homology between the C-terminal DNA binding domains of Escherichia coli and M. tuberculosis DNA topoisomerase I proteins.
Results:
A new protocol for expression and purification of recombinant M. tuberculosis DNA topoisomerase I (MtTOP) has been developed to produce enzyme of much higher specific activity than previously characterized recombinant enzyme. MtTOP was found to be less efficient than E. coli DNA topoisomerase I (EcTOP) in removal of remaining negative supercoils from partially relaxed DNA. DNA cleavage by MtTOP was characterized for the first time. Comparison of DNA cleavage site selectivity with EcTOP showed differences in cleavage site preferences, but the preferred sites of both enzymes have a C nucleotide in the -4 position.
Conclusion:
Recombinant M. tuberculosis DNA topoisomerase I can be expressed as a soluble protein and purified in high yield from E. coli host with a new protocol. Analysis of DNA cleavage with M. tuberculosis DNA substrate showed that the preferred DNA cleavage sites have a C nucleotide in the -4 position.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/18</link>
                <dc:creator>Thirunavukkarasu Annamalai</dc:creator>
                <dc:creator>Neil Dani</dc:creator>
                <dc:creator>Bokun Cheng</dc:creator>
                <dc:creator>Yuk-Ching Tse-Dinh</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:18</dc:source>
        <dc:date>2009-06-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-18</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>18</prism:startingPage>
        <prism:publicationDate>2009-06-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2091/10/17">
        <title>DNA binding kinetics of two response regulators, PlnC and PlnD, from the bacteriocin regulon of Lactobacillus plantarum C11</title>
        <description>Background:
Bacteriocin production in the lactic acid bacterium Lactobacillus plantarum C11 is regulated through a quorum sensing based pathway involving two highly homologous response regulators (59% identity and 76% similarity), PlnC as a transcriptional activator and PlnD as a repressor. Previous in vitro studies have shown that both regulators bind, as homodimers, to the same DNA regulatory repeats to exert their regulatory functions. As the genes for these two proteins are located on the same auto-regulatory operon, hence being co-expressed upon gene activation, it is plausible that their opposite functions must somehow be differentially regulated, either in terms of timing and/or binding kinetics, so that their activities do not impair each other in an uncontrolled manner. To understand the nature behind this potential differentiation, we have studied the binding kinetics of the two regulators on five target promoters (PplnA, PplnM, PplnJ, PplnE and PplnG) from the bacteriocin regulon of L. plantarum C11.
Results:
By using surface plasmon resonance spectroscopy we obtained parameters such as association rates, dissociation rates and dissociation constants, showing that the two regulators indeed differ greatly from each other in terms of cooperative binding and binding strength to the different promoters. For instance, cooperativity is very strong for PlnC binding to the promoter of the regulatory operon (PplnA), but not to the promoter of the transport operon (PplnG), while the opposite is seen for PlnD binding to these two promoters. The estimated affinity constants indicate that PlnC can bind to PplnA to activate transcription of the key regulatory operon plnABCD without much interference from PlnD, and that the repressive function of PlnD might act through a different mechanism than repression of the regulatory operon.
Conclusion:
We have characterised the DNA binding kinetics of the two regulators PlnC and PlnD from the bacteriocin locus in L. plantarum C11. Our data show that PlnC and PlnD, despite their strong homology to each other, differ greatly from each other in terms of binding affinity and cooperativity to the different promoters of the pln regulon.</description>
        <link>http://www.biomedcentral.com/1471-2091/10/17</link>
                <dc:creator>Daniel Straume</dc:creator>
                <dc:creator>Rune Johansen</dc:creator>
                <dc:creator>Magnar Bjoras</dc:creator>
                <dc:creator>Ingolf Nes</dc:creator>
                <dc:creator>Dzung Diep</dc:creator>
                <dc:source>BMC Biochemistry 2009, 10:17</dc:source>
        <dc:date>2009-06-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2091-10-17</dc:identifier>
        <prism:publicationName>BMC Biochemistry</prism:publicationName>
        <prism:issn>1471-2091</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2009-06-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
